Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Kratom Abuse Potential 2021: An Updated Eight Factor Analysis
Jack E. Henningfield, Daniel W. Wang, Marilyn A. Huestis
Frontiers in Pharmacology (2022) Vol. 12
Open Access | Times Cited: 25

Showing 25 citing articles:

An update on the clinical pharmacology of kratom: uses, abuse potential, and future considerations
Christopher R. McCurdy, Abhisheak Sharma, Kirsten E. Smith, et al.
Expert Review of Clinical Pharmacology (2024) Vol. 17, Iss. 2, pp. 131-142
Closed Access | Times Cited: 18
Understanding Kratom Use: A Guide for Healthcare Providers
Marc T. Swogger, Kirsten E. Smith, Albert Garcia‐Romeu, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 52
Responses to a “Typical” Morning Dose of Kratom in People Who Use Kratom Regularly: A Direct-Observation Study
Kirsten E. Smith, Jeffrey M. Rogers, Abhisheak Sharma, et al.
Journal of Addiction Medicine (2024) Vol. 18, Iss. 2, pp. 144-152
Closed Access | Times Cited: 12
Kratom safety and toxicology in the public health context: research needs to better inform regulation
Jack E. Henningfield, Oliver Grundmann, Marilyn A. Huestis, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 11
Exploring the Therapeutic Potential of Mitragynine and Corynoxeine: Kratom-Derived Indole and Oxindole Alkaloids for Pain Management
Ahmed S. Alford, Heitor Moreno, Menny M. Benjamin, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 2, pp. 222-222
Open Access | Times Cited: 1
Psychedelic drug abuse potential assessment research for new drug applications and Controlled Substances Act scheduling
Jack E. Henningfield, Marion A. Coe, Roland R. Griffiths, et al.
Neuropharmacology (2022) Vol. 218, pp. 109220-109220
Open Access | Times Cited: 24
Kratom ( Mitragyna speciosa Korth.) Use Among Poly-Drug Users in Southeast Asia: A Systematic Review
Neshalatha Govarthnapany, Roman Gabrhelík, Darshan Singh
Journal of Psychoactive Drugs (2025), pp. 1-11
Closed Access
Home Care and the Patient Taking Kratom
Heidi Sykora
Home Healthcare Now (2025) Vol. 43, Iss. 2, pp. 122-124
Closed Access
Analysis of the molecular interaction of mitragynine from kratom with human α 1 -acid glycoprotein: biophysical and molecular modeling investigations
Khairul Azreena Bakar, Shevin Rizal Feroz
Journal of Biomolecular Structure and Dynamics (2025), pp. 1-17
Closed Access
Effects of kratom on driving: Results from a cross-sectional survey, ecological momentary assessment, and pilot simulated driving Study
C. Austin Zamarripa, Tory R. Spindle, Leigh V. Panlilio, et al.
Traffic Injury Prevention (2024) Vol. 25, Iss. 4, pp. 594-603
Open Access | Times Cited: 3
Evaluation of toxicity profile of kratom (Mitragyna speciosa Korth) decoction in rats
Zurina Hassan, Darshan Singh, Farah Wahida Suhaimi, et al.
Regulatory Toxicology and Pharmacology (2023) Vol. 143, pp. 105466-105466
Closed Access | Times Cited: 7
Respiratory effects of oral mitragynine and oxycodone in a rodent model
Jack E. Henningfield, Joseph V. Rodricks, Aaron M. Magnuson, et al.
Psychopharmacology (2022) Vol. 239, Iss. 12, pp. 3793-3804
Open Access | Times Cited: 12
Receptor Selectivity and Therapeutic Potential of Kratom in Substance Use Disorders
Sushobhan Mukhopadhyay, Sampa Gupta, Jenny L. Wilkerson, et al.
Current Addiction Reports (2023) Vol. 10, Iss. 2, pp. 304-316
Closed Access | Times Cited: 6
Associations Between Kratom-Related State Policy Environments and Kratom Use in a Nationally Representative Population in the United States
Matthew S. Ellis, Mance E. Buttram, Alyssa Forber, et al.
Journal of Psychoactive Drugs (2023) Vol. 56, Iss. 3, pp. 333-341
Closed Access | Times Cited: 6
Examining the Psychoactive Differences between Kratom Strains
Guido Huisman, Maximilian Menke, Oliver Grundmann, et al.
International Journal of Environmental Research and Public Health (2023) Vol. 20, Iss. 14, pp. 6425-6425
Open Access | Times Cited: 6
What Is the Kratom Overdose Risk? A Systematic Literature Review
Corneliu N. Stanciu, Samantha A. Gnanasegaram, Gerald L. Rader, et al.
Current Addiction Reports (2023) Vol. 10, Iss. 1, pp. 9-28
Closed Access | Times Cited: 5
Beneficial and Adverse Health Effects of Kratom (Mitragyna speciosa): A Critical Review of the Literature
J. Thomas Heywood, S. Smallets, Dennis J. Paustenbach
Food and Chemical Toxicology (2024) Vol. 192, pp. 114913-114913
Closed Access | Times Cited: 1
Drug testing for mitragynine and kratom: Analytical challenges and medico‐legal considerations
Anders Helander, Alexia Rylski
Drug Testing and Analysis (2022) Vol. 15, Iss. 2, pp. 213-219
Open Access | Times Cited: 6
Kratom Alkaloids, Cannabinoids, and Chronic Pain: Basis of Potential Utility and Role in Therapy
Daniel Farkas, Ziva D. Cooper, Laila N. Heydari, et al.
Cannabis and Cannabinoid Research (2023)
Closed Access | Times Cited: 3
Pharmacology and toxicology of kratom
Miroslav Pohanka
Bratislavské lekárske listy/Bratislava medical journal (2023) Vol. 124, Iss. 12, pp. 896-902
Open Access | Times Cited: 2
Kratom's rising role in the potential exacerbation of mental health disorders: A case report and review of the literature
Maxsaya Baez Nuñez, Annika Dhingra, Myra Dhingra, et al.
Psychiatry Research Case Reports (2022) Vol. 1, Iss. 2, pp. 100069-100069
Open Access | Times Cited: 3
Kratom (Mitragynia speciosa), seizure latency, anxiety, and “social” behavior in the zebrafish
Janelle A Peña-Jiménez, Edwin A Suárez- Zayas, Rígel Licier, et al.
Pharmacy & Pharmacology International Journal (2024) Vol. 12, Iss. 2, pp. 71-73
Open Access
Characterization of kratom use and knowledge at a rural, Oregon community health center
Kerri Raven Cauldron, Natalea Braden‐Suchy, Adriane N. Irwin
Journal of the American Pharmacists Association (2024) Vol. 64, Iss. 5, pp. 102138-102138
Closed Access
Kratom (<i>Mitragyna speciosa</i>) Use and Mental Health: A Systematic Review and Multilevel Meta-Analysis
Yuting Yang, Christian P. Müller, Darshan Singh
European Addiction Research (2024) Vol. 30, Iss. 4, pp. 252-274
Closed Access
Kratom: a primer for pain physicians
Trent Emerick, Shravani Durbhakula, Maria R. Eibel, et al.
Current Opinion in Anaesthesiology (2024) Vol. 37, Iss. 5, pp. 575-580
Closed Access
Page 1

Scroll to top